In 2020, physicians caring for Medicare beneficiaries ordered nearly 90,000 tests to diagnose leukemia and hereditary breast and colon cancer. For seniors battling cancers, access to routine testing can be lifesaving. Learn how we can #StopLabCuts: https://t.co/awJXU2q2YK.
ACLA thanks @RepDavidRouzer for fighting for seniors’ access to clinical laboratory services and keeping our nation’s laboratory infrastructure healthy through the Saving Access to Laboratory Services Act. #StopLabCuts https://t.co/FTKKf2ADOs
AMP is conducting a survey to advocate for improved payment rates & effective #PAMA reform. We ask kindly for your assistance in completing this survey, which should take 15-20 minutes to complete. Thank you! #StopLabCuts#molpath#pathtwitter https://t.co/YT3NXOELUi
Without Congressional action, reimbursement for routine laboratory tests used to diagnose and monitor serious chronic conditions, including diabetes, will be cut an additional 9-14% in 2023. Tell Congress to #StopLabCuts: https://t.co/bZOWKebpob
#Labvocate#IamASCLS
Passing the Saving Access to Laboratory Services Act (SALSA) would help protect access to the most common laboratory tests that America’s patients depend on. Congress: Please pass SALSA and #StopLabCuts. Learn more: https://t.co/uFELUZBrjW.
Without Congressional action, impending #PAMA cuts could compromise access to many clinical laboratory tests used to diagnose and monitor autoimmune diseases for America’s seniors. Join @ACLAlabs in our efforts to #StopLabCuts: https://t.co/QV8xj6Aa2Q.
Thank you @RepPeteAguilar for cosponsoring the Saving Access to Laboratory Services Act. ACLA is grateful & proud of the ongoing bipartisan, bicameral collaboration on legislation preserving lifesaving lab tests for seniors. #StopLabCuts https://t.co/FTKKf2ADOs
#DYK? Medicare reimbursement cuts resulting from #PAMA may weaken our clinical laboratories’ investment in the next generation of diagnostic tests, including those that diagnose cancer. Learn more and help #StopLabCuts: https://t.co/uhkvoVTflo
#Labvocate#IamASCLS
Not just in health systems, academic, small rural hospitals, critical access, skilled nursing facilities, doctors offices and so much more! #StopLabCuts#Labvocate
#DYK? Scheduled #Medicare reimbursement cuts could compromise access to many of the clinical laboratory tests used to diagnose, monitor, and manage autoimmune diseases for America’s seniors. Learn how we can #StopLabCuts: https://t.co/Mt0X0JKHRg.
We launched the #StopLabCuts campaign to raise awareness of impending Medicare cuts to lab tests scheduled to resume in January & the negative impact they could have on care delivery, the clinical lab infrastructure, and diagnostic innovation. Learn more: https://t.co/hvhgL73gl4
Unless Congress intervenes, reimbursement for lab tests used to diagnose heart disease will decrease by an additional 14% in 2023, making it potentially more difficult for patients to access the tests they need. Tell Congress to #StopLabCuts: https://t.co/2LeU20pCVu.
Without congressional action, reimbursement for routine laboratory tests used to diagnose and monitor serious chronic conditions, including diabetes, will be cut an additional 9–14% in 2023. Join ARUP in asking Congress to #StopLabCuts: https://t.co/HfjKIrLTpW
Thank you Rep. @Call_Me_Dutch for taking action to safeguard seniors’ access to crucial lab tests and services. We urge Congress to pass the Saving Access to Laboratory Services Act, permanently easing Medicare cuts that weaken access & our lab infrastructure. #StopLabCuts
@amyklobuchar Senator Klobuchar please co-sponsor SALSA and #StopLabCuts. America needs a strong clinical laboratory infrastructure to support the delivery of routine patient care. Cuts of an additional 9-14% in 2023 will be catastrophic. Learn more: https://t.co/2tpAjYBr2u
ACLA thanks @RepJohnJoyce for fighting for seniors’ access to clinical laboratory services and keeping our nation’s laboratory infrastructure healthy through the Saving Access to Laboratory Services Act. We must #StopLabCuts and permanently ease Medicare payment cuts.
In 2020, over 28 million tests were ordered to diagnose heart disease. Congress can now protect patients’ access to these tests and more by addressing scheduled cuts to #Medicare reimbursement. Learn more about our efforts to #StopLabCuts: https://t.co/Mt0X0JKHRg.